Avalo Therapeutics
AVTX
AVTX
20 hedge funds and large institutions have $84.7M invested in Avalo Therapeutics in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
Holders
20
Holding in Top 10
1
Calls
$152K
Puts
–
Top Buyers
| 1 | +$5.08M | |
| 2 | +$321K | |
| 3 | +$292K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$169K |
| 5 |
Goldman Sachs
New York
|
+$81K |
Top Sellers
| 1 | -$114K | |
| 2 | -$64K | |
| 3 | -$42K | |
| 4 |
DBIA
Dumont & Blake Investment Advisors
Princeton,
New Jersey
|
-$39.9K |
| 5 |
Morgan Stanley
New York
|
-$17K |